[1] Fitzsimmons REB, Mazurek MS, Soos A, et al. Mesenchymal stromal/stem cells in regenerative medicine and tissue engineering[J]. Stem Cells Int, 2018, 2018:8031718. [2] HuangXY, Li ZH, Liu AQ, et al. Microenvironment influences odontogenic mesenchymal stem cells mediated dental pulp regeneration[J]. Front Physiol, 2021, 12:656588. [3] He S, Sharpless NE. Senescence in health and disease[J]. Cell, 2017, 169(6):1000-1011. [4] Frobel J, Hemeda H, Lenz M,et al. Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells[J]. Stem Cell Reports, 2014, 3(3):414-422. [5] 吴晓恋, 傅稼耀, 武文婧, 等. 外泌体对老龄小鼠骨髓间充质干细胞衰老影响的初步研究[J]. 口腔颌面外科杂志, 2020, 30(3):137-143. [6] Zhang YP, Xing YX, Jia LL, et al. An in vitro comparative study of multisource derived human mesenchymal stem cells for bone tissue engineering[J]. Stem Cells Dev, 2018, 27(23):1634-1645. [7] Pittenger MF, MacKay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells[J]. Science, 1999, 284(5411):143-147. [8] Dominici M,le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J]. Cytotherapy, 2006, 8(4):315-317. [9] Franzke B, Halper B, Hofmann M,et al. The impact of six months strength training, nutritional supplementation or cognitive training on DNA damage in institutionalised elderly[J]. Mutagenesis, 2015, 30(1):147-153. [10] Liu J, Wang LH, Wang ZG, et al. Roles of telomere biology in cell senescence, replicative and chronological ageing[J]. Cells, 2019, 8(1):E54. [11] Wiley CD, Velarde MC, Lecot P, et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype[J]. Cell Metab, 2016, 23(2):303-314. [12] Burova E, Borodkina A, Shatrova A,et al. Sublethal oxidative stress induces the premature senescence of human mesenchymal stem cells derived from endometrium[J]. Oxid Med Cell Longev, 2013, 2013:474931. [13] Ma Y, Qi M, An Y,et al. Autophagy controls mesenchymal stem cell properties and senescence during bone aging[J]. Aging Cell, 2018, 17(1):e12709. DOI:10.1111/acel.12709. [14] Saidova AA, Vorobjev IA. Lineage commitment, signaling pathways, and the cytoskeleton systems in mesenchymal stem cells[J]. Tissue Eng Part B Rev, 2020, 26(1):13-25. [15] Collado M, Serrano M. The power and the promise of oncogene-induced senescence markers[J]. Nat Rev Cancer, 2006, 6(6):472-476. [16] Nakagami H. Cellular senescence and senescence-associated T cells as a potential therapeutic target[J]. Geriatr Gerontol Int, 2020, 20(2):97-100. [17] Calcinotto A, Kohli J, Zagato E,et al. Cellular senescence:Aging, cancer, and injury[J]. Physiol Rev, 2019, 99(2):1047-1078. [18] Turinetto V, Vitale E, Giachino C. Senescence inhuman mesenchymal stem cells:Functional changes and implications in stem cell-based therapy[J]. Int J Mol Sci, 2016, 17(7):E1164. [19] Martel J, Ojcius DM, Wu CY, et al. Emerging use of senolytics and senomorphics against aging and chronic diseases[J]. Med Res Rev, 2020, 40(6):2114-2131. [20] Amaya-Montoya M, Pérez-Londoño A, Guatibonza-García V, et al. Cellular senescence as a therapeutic target for age-related diseases:A review[J]. Adv Ther, 2020, 37(4):1407-1424. [21] LeeBY, Han JG, Im JS, et al. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase[J]. Aging Cell, 2006, 5(2):187-195. [22] Chandra T, Ewels PA, Schoenfelder S, et al. Global reorganiza-tion of the nuclear landscape in senescent cells[J]. Cell Rep, 2015, 10(4):471-483. [23] Zhang WQ, Li JY, Suzuki K, et al. Aging stem cells. A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging[J]. Science, 2015, 348(6239):1160-1163. [24] Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease[J]. Cell, 2017, 168(6):960-976. [25] Liu HL, Huang B, Xue SL, et al. Functional crosstalk between mTORC1/p70S6K pathway and heterochromatin organization in stress-induced senescence of MSCs[J]. Stem Cell Res Ther, 2020, 11(1):279. [26] Zhou T, Yan YR, Zhao CC, et al. Resveratrol improves osteogenic differentiation of senescent bone mesenchymal stem cells through inhibiting endogenous reactive oxygen species production via AMPK activation[J]. Redox Rep, 2019, 24(1):62-69. [27] Yoon DS, Choi Y, Choi SM, et al. Different effects of resveratrol on early and late passage mesenchymal stem cells through β-catenin regulation[J]. Biochem Biophys Res Commun, 2015, 467(4):1026-1032. [28] Wang XX, Ma SS, Meng N, et al. Resveratrol exerts dosage-dependent effects on the self-renewal and neural differentiation of hUC-MSCs[J]. Mol Cells, 2016, 39(5):418-425. [29] Yoon DS, Choi Y, Jang Y, et al. SIRT1 directly regulates SOX2 to maintain self-renewal and multipotency in bone marrow-derived mesenchymal stem cells[J]. Stem Cells, 2014, 32(12):3219-3231. [30] Kornienko JS, Smirnova IS, Pugovkina NA, et al. High doses of synthetic antioxidants induce premature senescence in cultivated mesenchymal stem cells[J]. Sci Rep, 2019, 9(1):1296. [31] Liao NS, Shi YJ, Zhang CL, et al. Antioxidants inhibit cell senescence and preserve stemness of adipose tissue-derived stem cells by reducing ROS generation during long-term in vitro expansion[J]. Stem Cell Res Ther, 2019, 10(1):306. [32] Zhou L, Chen X, Liu T,et al. Melatonin reverses H2 O2 -induced premature senescence in mesenchymal stem cells via the SIRT1-dependent pathway[J]. J Pineal Res, 2015, 59(2):190-205. [33] Han YS, Kim SM, Lee JH, et al. Melatonin protects chronic kidney disease mesenchymal stem cells against senescence via PrPC -dependent enhancement of the mitochondrial function[J]. J Pineal Res, 2019, 66(1):e12535. DOI:10.1111/jpi.12535. [34] Fang J, Yan Y, Teng X,et al. Melatonin prevents senescence of canine adipose-derived mesenchymal stem cells through activating NRF2 and inhibiting ER stress[J]. Aging (Albany NY), 2018, 10(10):2954-2972. [35] Yun SP, Han YS, Lee JH, et al. Melatonin rescues mesenchymal stem cells from senescence induced by the uremic toxin p-cresol via inhibiting mTOR-dependent autophagy[J]. Biomol Ther (Seoul), 2018, 26(4):389-398. [36] Pirmoradi S, Fathi E, Farahzadi R,et al. Curcumin affects adipose tissue-derived mesenchymal stem cell aging through TERT gene expression[J]. Drug Res (Stuttg), 2018, 68(4):213-221. [37] Mato-Basalo R, Morente-López M, Arntz OJ, et al. Therapeutic potential for regulation of the nuclear factor kappa-B transcription factor p65 to prevent cellular senescence and activation of pro-inflammatory in mesenchymal stem cells[J]. Int J Mol Sci, 2021, 22(7):3367. [38] Gao B, Lin XS, Jing H, et al. Local delivery of tetramethy-lpyrazine eliminates the senescent phenotype of bone marrow mesenchymal stromal cells and creates an anti-inflammatory and angiogenic environment in aging mice[J]. Aging Cell, 2018, 17(3):e12741. DOI:10.1111/acel.12741. [39] Shin JH, Jeon HJ, Park J, et al. Epigallocatechin-3-gallate prevents oxidative stress-induced cellular senescence in human mesenchymal stem cells via Nrf2[J]. Int J Mol Med, 2016, 38(4):1075-1082. [40] Geng LL, Liu ZP, Zhang WQ, et al. Chemical screen identifies a geroprotective role of quercetin in premature aging[J]. Protein Cell, 2019, 10(6):417-435. [41] Kuang YC, Hu B, Feng G, et al. Metformin prevents against oxidative stress-induced senescence in human periodontal ligament cells[J]. Biogerontology, 2020, 21(1):13-27. [42] Kim H, Yu MR, Lee H, et al. Metformin inhibits chronic kidney disease-induced DNA damage and senescence of mesenchymal stem cells[J]. Aging Cell, 2021, 20(2):e13317. DOI:10.1111/acel.13317. [43] 苏路路, 管博文, 樊飞跃, 等. 衰老细胞清除剂研究进展[J]. 中国药理学通报, 2019, 35(10):1333-1337. [44] Hickson LJ, Langhi Prata LGP, Bobart SA, et al. Senolytics decrease senescent cells in humans:Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease[J]. E Bio Medicine, 2019, 47:446-456. [45] Zhu Y, Tchkonia T, Pirtskhalava T,et al. The Achilles' heel of senescent cells:From transcriptome to senolytic drugs[J]. Aging Cell, 2015, 14(4):644-658. [46] Grezella C, Fernandez-Rebollo E, Franzen J,et al. Effects of senolytic drugs on human mesenchymal stromal cells[J]. Stem Cell Res Ther, 2018, 9(1):108. [47] Fuhrmann-Stroissnigg H, LingYY, Zhao J, et al. Identification of HSP90 inhibitors as a novel class of senolytics[J]. Nat Commun, 2017, 8(1):422. |